By the presentation Feburary 1099 patients, 638 prescribers, 1.72 patients per prescriber
March 1868 patients, 1052 prescribers, 1.77 patients per prescriber
Depending on rapidity of clinical practice could see 20-50 patients a day, a lot more if they are authorizing based on asynchronous online assessment, not saying that is a good thing but is an option on getsofdra. But each derm is seeing up to 400-1000pts a month.
In clinical practice at first you prescribe it to those who have failed previous therapy, then you see what happens in those patients compared to your experience with other treatments. Free drug that works ok and gets sent quickly in the USA should beat co-pay drug that works ok. Co-pay goes by calendar year so it will get more profitable as the year goes on.
10,000 dermatologists, setup seems different half are medical dermatologists that don't really do acne/hyperhidrosis more for biologics, more like Australian derm people so I think a lot of others are then like derm nurse practitioners or physician assistants, not really existent in Australia would more go through GP. The company seems to be using a derm physician assistant for promotion.
Good to see the 1900 prescribers for 1m scripts of minocycline but that is an old drug and I'm pretty sure your family doctors would be prescribing antibiotics for acne anyway, but the 1900 must have come from somewhere. Tim got the Sofdra prescriber wrong though.
Qbrexza revenue was never that high so that is a worry and it seems like they are completely funding scripts upfront as long as if later the co-pay will run out and they will get net revenue.
So cashflow could be given payment terms D1 -120% gross (-USD 1200), D31 -240% gross(-USD 2400), D61 -320% gross (-USD 3200), D91 -360% gross (-USD 3600) then should decrease from there.
Matt did say that they were getting USD 400 net, I assumed that meant that is what they are achieving now but it could be that the lifetime value of the patient is then USD 400 and upfront they are getting a lot less as it is the only way they could be burning cash so quickly they need to raise the debt so quickly with attached low strike price warrants.
- Forums
- ASX - By Stock
- BOT
- Bot Chart
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
0.00%
!
30.0¢

Bot Chart, page-21481
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M |
Open | High | Low | Value | Volume |
30.5¢ | 31.0¢ | 30.0¢ | $2.131M | 7.020M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 504695 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 38124 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 504695 | 0.300 |
12 | 494795 | 0.295 |
16 | 784411 | 0.290 |
13 | 837934 | 0.285 |
30 | 395849 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 38124 | 3 |
0.310 | 367000 | 7 |
0.315 | 818032 | 7 |
0.320 | 388953 | 8 |
0.325 | 262393 | 4 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |